纳米超声造影剂的研究进展与临床转化
Research Progress and Clinical Translation of Nanosized Ultrasound Contrast Agents
DOI: 10.12677/acm.2025.151218, PDF,   
作者: 张延美：西安医学院研究生院，陕西 西安；张 莉*：空军军医大学唐都医院超声医学科，陕西 西安
关键词: 纳米超声造影剂；临床转化；纳米材料；超声造影成像；Nanosized Ultrasound Contrast Agents； Clinical Translation； Nanomaterials； Ultrasonography
摘要: 随着技术的发展，纳米超声造影剂的研究越来越多，除了常规的微泡结构纳米超声造影剂，还出现了许多新型的纳米超声造影剂，这些纳米超声造影剂经过修饰或负载药物被赋予了疾病治疗能力。本文针对这些纳米超声造影剂各自的优缺点和实现临床转化中遇到的困难进行综述。
Abstract: With the development of technology, nanosized ultrasound contrast agents are increasingly being investigated. In addition to conventional microbubble-structured nanosized ultrasound contrast agents, a number of novel nanosized ultrasound contrast agents have emerged that have been modified or loaded with drugs to be endowed with disease-treating capabilities. This paper provides a review of the advantages and disadvantages of each of these nanosized ultrasound contrast agents and the difficulties encountered in achieving clinical translation.
文章引用：张延美, 张莉. 纳米超声造影剂的研究进展与临床转化[J]. 临床医学进展, 2025, 15(1): 1627-1632. https://doi.org/10.12677/acm.2025.151218

参考文献

[1] Kim, J., Cho, H., Lim, D., Joo, M.K. and Kim, K. (2023) Perspectives for Improving the Tumor Targeting of Nanomedicine via the EPR Effect in Clinical Tumors. International Journal of Molecular Sciences, 24, Article No. 10082. [Google Scholar] [CrossRef] [PubMed]
[2] Lahooti, B., Akwii, R.G., Zahra, F.T., Sajib, M.S., Lamprou, M., Alobaida, A., et al. (2023) Targeting Endothelial Permeability in the EPR Effect. Journal of Controlled Release, 361, 212-235. [Google Scholar] [CrossRef] [PubMed]
[3] Ma, Z., Zhang, Y., Zhu, Y., Cui, M., Liu, Y., Duan, Y., et al. (2024) Construction of a Tumor-Targeting Nanobubble with Multiple Scattering Interfaces and Its Enhancement of Ultrasound Imaging. International Journal of Nanomedicine, 19, 4651-4665. [Google Scholar] [CrossRef] [PubMed]
[4] Perera, R.H., de Leon, A., Wang, X., Wang, Y., Ramamurthy, G., Peiris, P., et al. (2020) Real Time Ultrasound Molecular Imaging of Prostate Cancer with PSMA-Targeted Nanobubbles. Nanomedicine: Nanotechnology, Biology and Medicine, 28, Article ID: 102213. [Google Scholar] [CrossRef] [PubMed]
[5] Unga, J., Kageyama, S., Suzuki, R., Omata, D. and Maruyama, K. (2019) Scale-Up Production, Characterization and Toxicity of a Freeze-Dried Lipid-Stabilized Microbubble Formulation for Ultrasound Imaging and Therapy. Journal of Liposome Research, 30, 297-304. [Google Scholar] [CrossRef] [PubMed]
[6] Yu, Z., Wang, Y., Xu, D., Zhu, L., Hu, M., Liu, Q., et al. (2020) G250 Antigen-Targeting Drug-Loaded Nanobubbles Combined with Ultrasound Targeted Nanobubble Destruction: A Potential Novel Treatment for Renal Cell Carcinoma. International Journal of Nanomedicine, 15, 81-95. [Google Scholar] [CrossRef] [PubMed]
[7] 辛莹, 周厚妊, 张月. 纳米级靶向超声造影剂在癌症诊疗中的研究进展[J]. 医学影像学杂志, 2021, 31(6): 1067-1070.
[8] 姜一弘, 吕苇, 杨佳琪, 等. 双模态纳米级肿瘤靶向超声造影剂的制备及对比研究[J]. 中国超声医学杂志, 2020, 36(10): 950-953.
[9] 张月, 周厚妊, 罗语岑, 等. HER2靶向载HSV-TK基因并具有核定位效应的纳米超声造影剂制备[J]. 山东医药, 2021, 61(16): 20-23.
[10] 张姗. 纳米级AMH靶向超声造影剂的制备及其对大鼠移植卵巢靶向显影的初步研究[D]: [博士学位论文]. 乌鲁木齐: 新疆医科大学, 2020.
[11] Li, H., Zhang, Y., Shu, H., Lv, W., Su, C. and Nie, F. (2022) Highlights in Ultrasound-Targeted Microbubble Destruction-Mediated Gene/Drug Delivery Strategy for Treatment of Malignancies. International Journal of Pharmaceutics, 613, Article ID: 121412. [Google Scholar] [CrossRef] [PubMed]
[12] Li, Y., Du, M., Fang, J., Zhou, J. and Chen, Z. (2021) UTMD Promoted Local Delivery of miR-34a-Mimic for Ovarian Cancer Therapy. Drug Delivery, 28, 1616-1625. [Google Scholar] [CrossRef] [PubMed]
[13] Qiu, Y., Wu, Z., Chen, Y., Liao, J., Zhang, Q., Wang, Q., et al. (2023) Nano Ultrasound Contrast Agent for Synergistic Chemo‐Photothermal Therapy and Enhanced Immunotherapy against Liver Cancer and Metastasis. Advanced Science, 10, Article ID: 2300878. [Google Scholar] [CrossRef] [PubMed]
[14] Dong, T., Jiang, J., Zhang, H., Liu, H., Zou, X., Niu, J., et al. (2021) PFP@PLGA/Cu12Sb4S13-Mediated PTT Ablates Hepatocellular Carcinoma by Inhibiting the RAS/MAPK/MT-CO1 Signaling Pathway. Nano Convergence, 8, Article No. 29. [Google Scholar] [CrossRef] [PubMed]
[15] Guo, M., Du, W., Lyu, N., Chen, X., Du, Y., Wang, H., et al. (2019) Ultra‐Early Diagnosis of Acute Myocardial Infarction in Rats Using Ultrasound Imaging of Hollow Double‐Layer Silica Nanospheres. Advanced Healthcare Materials, 9, Article ID: 1901155. [Google Scholar] [CrossRef] [PubMed]
[16] Yang, X., Zhao, M., Wu, Z., Chen, C., Zhang, Y., Wang, L., et al. (2022) Nano-Ultrasonic Contrast Agent for Chemoimmunotherapy of Breast Cancer by Immune Metabolism Reprogramming and Tumor Autophagy. ACS Nano, 16, 3417-3431. [Google Scholar] [CrossRef] [PubMed]
[17] Li, X., Sui, Z., Li, X., Xu, W., Guo, Q., Sun, J., et al. (2018) Perfluorooctylbromide Nanoparticles for Ultrasound Imaging and Drug Delivery. International Journal of Nanomedicine, 13, 3053-3067. [Google Scholar] [CrossRef] [PubMed]
[18] Hallam, K.A., Nikolai, R.J., Jhunjhunwala, A. and Emelianov, S.Y. (2024) Laser-Activated Perfluorocarbon Nanodroplets for Intracerebral Delivery and Imaging via Blood-Brain Barrier Opening and Contrast-Enhanced Imaging. Journal of Nanobiotechnology, 22, Article No. 356. [Google Scholar] [CrossRef] [PubMed]
[19] Spatarelu, C., Jandhyala, S. and Luke, G.P. (2023) Dual-Drug Loaded Ultrasound-Responsive Nanodroplets for On-Demand Combination Chemotherapy. Ultrasonics, 133, Article ID: 107056. [Google Scholar] [CrossRef] [PubMed]
[20] Vezeridis, A.M., de Gracia Lux, C., Barnhill, S.A., Kim, S., Wu, Z., Jin, S., et al. (2019) Fluorous-Phase Iron Oxide Nanoparticles as Enhancers of Acoustic Droplet Vaporization of Perfluorocarbons with Supra-Physiologic Boiling Point. Journal of Controlled Release, 302, 54-62. [Google Scholar] [CrossRef] [PubMed]
[21] Ai, C., Sun, X., Xiao, S., Guo, L., Shang, M., Shi, D., et al. (2023) CAFs Targeted Ultrasound-Responsive Nanodroplets Loaded V9302 and GLULsiRNA to Inhibit Melanoma Growth via Glutamine Metabolic Reprogramming and Tumor Microenvironment Remodeling. Journal of Nanobiotechnology, 21, Article No. 214. [Google Scholar] [CrossRef] [PubMed]
[22] Lea-Banks, H., Meng, Y., Wu, S., Belhadjhamida, R., Hamani, C. and Hynynen, K. (2021) Ultrasound-Sensitive Nanodroplets Achieve Targeted Neuromodulation. Journal of Controlled Release, 332, 30-39. [Google Scholar] [CrossRef] [PubMed]
[23] Pan, Y., Li, Y., Li, Y., Zheng, X., Zou, C., Li, J., et al. (2022) Nanodroplet‐Coated Microbubbles Used in Sonothrombolysis with Two‐Step Cavitation Strategy. Advanced Healthcare Materials, 12, Article ID: 2202281. [Google Scholar] [CrossRef] [PubMed]
[24] Xiao, S., Guo, L., Ai, C., Shang, M., Shi, D., Meng, D., et al. (2023) Ph-/Redox-Responsive Nanodroplet Combined with Ultrasound-Targeted Microbubble Destruction for the Targeted Treatment of Drug-Resistant Triple Negative Breast Cancer. ACS Applied Materials & Interfaces, 15, 8958-8973. [Google Scholar] [CrossRef] [PubMed]
[25] Xu, Y., Lu, Q., Sun, L., Feng, S., Nie, Y., Ning, X., et al. (2020) Nanosized Phase‐Changeable “Sonocyte” for Promoting Ultrasound Assessment. Small, 16, Article ID: 2002950. [Google Scholar] [CrossRef] [PubMed]
[26] Jang, Y., Park, J., Kim, P., Park, E., Sun, H., Baek, Y., et al. (2023) Development of Exosome Membrane Materials-Fused Microbubbles for Enhanced Stability and Efficient Drug Delivery of Ultrasound Contrast Agent. Acta Pharmaceutica Sinica B, 13, 4983-4998. [Google Scholar] [CrossRef] [PubMed]
[27] Deng, Q., Mi, J., Dong, J., Chen, Y., Chen, L., He, J., et al. (2022) Superiorly Stable Three-Layer Air Microbubbles Generated by Versatile Ethanol-Water Exchange for Contrast-Enhanced Ultrasound Theranostics. ACS Nano, 17, 263-274. [Google Scholar] [CrossRef] [PubMed]
[28] Tang, H., Zheng, Y. and Chen, Y. (2016) Materials Chemistry of Nanoultrasonic Biomedicine. Advanced Materials, 29, Article ID: 1604105. [Google Scholar] [CrossRef] [PubMed]
[29] Deng, Y., Zhang, X., Yang, X., Huang, Z., Wei, X., Yang, X., et al. (2021) Subacute Toxicity of Mesoporous Silica Nanoparticles to the Intestinal Tract and the Underlying Mechanism. Journal of Hazardous Materials, 409, Article ID: 124502. [Google Scholar] [CrossRef] [PubMed]
[30] Chalouni, C. and Doll, S. (2018) Fate of Antibody-Drug Conjugates in Cancer Cells. Journal of Experimental & Clinical Cancer Research, 37, Article No. 20. [Google Scholar] [CrossRef] [PubMed]
[31] Missaoui, W.N., Arnold, R.D. and Cummings, B.S. (2018) Toxicological Status of Nanoparticles: What We Know and What We Don’t Know. Chemico-Biological Interactions, 295, 1-12. [Google Scholar] [CrossRef] [PubMed]
[32] Lucas, A.T., Price, L.S., Schorzman, A. and Zamboni, W.C. (2017) Complex Effects of Tumor Microenvironment on the Tumor Disposition of Carrier-Mediated Agents. Nanomedicine, 12, 2021-2042. [Google Scholar] [CrossRef] [PubMed]
[33] Ragelle, H., Danhier, F., Préat, V., Langer, R. and Anderson, D.G. (2016) Nanoparticle-Based Drug Delivery Systems: A Commercial and Regulatory Outlook as the Field Matures. Expert Opinion on Drug Delivery, 14, 851-864. [Google Scholar] [CrossRef] [PubMed]

为你推荐